<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38921807</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>17</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Differential Gene Expression in the Upper Respiratory Tract following Acute COVID-19 Infection in Ambulatory Patients That Develop Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">510</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13060510</ELocationID><Abstract><AbstractText><b>Background:</b> Post-acute sequelae of COVID-19, or long COVID, is a condition characterized by persistent COVID-19 symptoms. As long COVID is defined by clinical criteria after an elapsed period, an opportunity for early intervention may aid in future prophylactic approaches; however, at present, the pathobiological mechanisms are multifactorial. By analyzing early virally infected upper respiratory tract tissue prior to eventual clinical diagnosis, it may be possible to identify biomarkers of altered immune response to facilitate future studies and interventions. <b>Methods:</b> This is a sub-group analysis of samples collected from those with confirmed COVID-19. RNA extraction from nasopharyngeal/mid-turbinate samples, sequencing, and bioinformatic analysis were performed to analyze long COVID and non-long COVID cohorts at day 14 post infection. Differences in mean viral load at various timepoints were analyzed as well as serological data. <b>Results:</b> We identified 26 upregulated genes in patients experiencing long COVID. Dysregulated pathways including complement and fibrinolysis pathways and IL-7 upregulation. Additionally, genes involved in neurotransmission were dysregulated, and the long COVID group had a significantly higher viral load and slower viral clearance. <b>Conclusions:</b> Uncovering early gene pathway abnormalities associated with eventual long COVID diagnosis may aid in early identification. We show that, post acute infection, in situ pathogenic deviations in viral response are associated with patients destined to meet consensus long COVID diagnosis that is entirely dependent on clinical factors. These results identify an important biological temporal window in the natural history of COVID-19 infection and long COVID pathogenesis amenable to testing from standard-of-care upper respiratory tract specimens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biondi</LastName><ForeName>Mia J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>School of Nursing, York University, Toronto, ON M3J 1P3, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Toronto Centre for Liver Disease, University Health Network, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addo</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahoor</LastName><ForeName>Muhammad Atif</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-2302-3689</Identifier><AffiliationInfo><Affiliation>Toronto Centre for Liver Disease, University Health Network, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvant</LastName><ForeName>Elsa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7635-7407</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Precision Diagnostics and Therapeutics Program, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>Bethany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Toronto Centre for Liver Disease, University Health Network, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smookler</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Toronto Centre for Liver Disease, University Health Network, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasif</LastName><ForeName>Sumaiyah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaete</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandel</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Michael Garron Hospital, Toronto, ON M4C 3E7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feld</LastName><ForeName>Jordan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Toronto Centre for Liver Disease, University Health Network, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Hubert</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7943-9099</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Precision Diagnostics and Therapeutics Program, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozak</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OV5-170347</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">differential gene expression</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pathway dysregulation</Keyword><Keyword MajorTopicYN="N">viral clearance</Keyword></KeywordList><CoiStatement>All other authors declare no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38921807</ArticleId><ArticleId IdType="pmc">PMC11206334</ArticleId><ArticleId IdType="doi">10.3390/pathogens13060510</ArticleId><ArticleId IdType="pii">pathogens13060510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalova L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Bruningk S.C., Hoch T., Fan B., Muzio G., Thompson R.C., Ceglarek L., Meledin R., Westermann P., Emmenegger M., et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024;383:eadg7942. doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak R.A., Salvant E., Chang V., Oikonomou A., Biondi M.J., Feld J.J., Armstrong S., Wasif S., Mubareka S., Nirmalarajah K., et al. Host Expression Profiling From Diagnostic Coronavirus Disease 2019 Swabs Associates Upper Respiratory Tract Immune Responses with Radiologic Lung Pathology and Clinical Severity. Open Forum Infect Dis. 2023;10:ofad190. doi: 10.1093/ofid/ofad190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad190</ArticleId><ArticleId IdType="pmc">PMC10173546</ArticleId><ArticleId IdType="pubmed">37180592</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler D., Mozsary C., Meydan C., Foox J., Rosiene J., Shaiber A., Mason C.E., Bhattacharya C., Young B., Ryon K., et al. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat. Commun. 2021;12:1660. doi: 10.1038/s41467-021-21361-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21361-7</ArticleId><ArticleId IdType="pmc">PMC7954844</ArticleId><ArticleId IdType="pubmed">33712587</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon H., Dean L.S., Jiyarom B., Khadka V., Deng Y., Nerurukar V.R., Park J., Koh Y., Devendra G., Shikuma C.M., et al. Single-cell RNA sequencing reveals characteristics of myeloid cells in pulmonary post-acute sequelae of SARS-CoV-2. bioRxiv. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10800799</ArticleId><ArticleId IdType="pubmed">38259488</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Tenoever B.R., Zachariou V., Lomvardas S., Schwartz R., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., Donohue S.E., Atchley-Challenner R., Shinnick D.J., Selvaggi C.A., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Feld J.J., Kandel C., Biondi M.J., Kozak R.A., Zahoor M.A., Lemieux C., Borgia S.M., Boggild A.K., Powis J., McCready J., et al. Peginterferon lambda for the treatment of outpatients with COVID-19: A phase 2, placebo-controlled randomised trial. Lancet Respir. Med. 2021;9:498&#x2013;510. doi: 10.1016/S2213-2600(20)30566-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30566-X</ArticleId><ArticleId IdType="pmc">PMC7906707</ArticleId><ArticleId IdType="pubmed">33556319</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G., Moreira Silva E.A.S., Medeiros Silva D.C., Thabane L., Campos V.H.S., Ferreira T.S., Santos C.V., Nogueira A.M., Almeida A.P., Savassi L.C., et al. Early Treatment with Pegylated Interferon Lambda for COVID-19. N. Engl. J. Med. 2023;388:518&#x2013;528. doi: 10.1056/NEJMoa2209760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2209760</ArticleId><ArticleId IdType="pmc">PMC9933926</ArticleId><ArticleId IdType="pubmed">36780676</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Meo A., Ma L., Yau K., Abe K.T., Colwill K., Gingras A.C., Yip P.M., Hladunewich M.A. Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patients. Clin. Biochem. 2023;121&#x2013;122:110681. doi: 10.1016/j.clinbiochem.2023.110681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2023.110681</ArticleId><ArticleId IdType="pubmed">37913837</ArticleId></ArticleIdList></Reference><Reference><Citation>Afgan E., Nekrutenko A., Gr&#xfc;ning B.A., Blankenberg D., Goecks J., Schatz M.C., Ostrovsky A.E., Mahmoud A., Lonie A.J., Syme A., et al. Correction to &#x2018;The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update&#x2019;. Nucleic Acids Res. 2022;50:8999.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers E.W., Bolton E.E., Brister J.R., Canese K., Chan J., Comeau D.C., Connor R., Funk K., Kelly C., Kim S., et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022;50:D20&#x2013;D26. doi: 10.1093/nar/gkab1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1112</ArticleId><ArticleId IdType="pmc">PMC8728269</ArticleId><ArticleId IdType="pubmed">34850941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E.Y., Tan C.M., Kou Y., Duan Q., Wang Z., Meirelles G.V., Clark N.R., Ma&#x2019;Ayan A. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128. doi: 10.1186/1471-2105-14-128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Bailey A., Kuleshov M.V., Clarke D.J., Evangelista J.E., Jenkins S.L., Ma&#x2019;ayan A., Jeon M., Jagodnik K.M., Kropiwnicki E., et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 2021;1:e90. doi: 10.1002/cpz1.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.90</ArticleId><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Franceschini A., Wyder S., Forslund K., Heller D., Huerta-Cepas J., Simonovic M., Roth A., Santos A., Tsafou K.P., et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447&#x2013;D452. doi: 10.1093/nar/gku1003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1003</ArticleId><ArticleId IdType="pmc">PMC4383874</ArticleId><ArticleId IdType="pubmed">25352553</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafran N., Shafran I., Ben-Zvi H., Sofer S., Sheena L., Krause I., Shlomai A., Goldberg E., Sklan E.H. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci. Rep. 2021;11:12703. doi: 10.1038/s41598-021-92220-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92220-0</ArticleId><ArticleId IdType="pmc">PMC8209102</ArticleId><ArticleId IdType="pubmed">34135459</ArticleId></ArticleIdList></Reference><Reference><Citation>Babicki S., Arndt D., Marcu A., Liang Y., Grant J.R., Maciejewski A., Wishart D.S. Heatmapper: Web-enabled heat mapping for all. Nucleic Acids Res. 2016;44:W147&#x2013;W153. doi: 10.1093/nar/gkw419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw419</ArticleId><ArticleId IdType="pmc">PMC4987948</ArticleId><ArticleId IdType="pubmed">27190236</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D. SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: A primer of neurodegeneration. Med. Hypotheses. 2020;144:110212. doi: 10.1016/j.mehy.2020.110212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110212</ArticleId><ArticleId IdType="pmc">PMC7448818</ArticleId><ArticleId IdType="pubmed">33254518</ArticleId></ArticleIdList></Reference><Reference><Citation>Leenaerts D., Loyau S., Mertens J.C., Boisseau W., Michel J.B., Lambeir A.M., Hendriks D., Jandrot-Perrus M. Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models. J. Thromb. Haemost. 2018;16:2057&#x2013;2069. doi: 10.1111/jth.14249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14249</ArticleId><ArticleId IdType="pubmed">30053349</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekele Y., Sui Y., Berzofksy J.A. IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant. Front. Immunol. 2021;12:737406. doi: 10.3389/fimmu.2021.737406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.737406</ArticleId><ArticleId IdType="pmc">PMC8484798</ArticleId><ArticleId IdType="pubmed">34603318</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>